Kamada Ltd (KMDA): Rasio rega marang dodolan

Logo korporat perusahaan Kamada Corp (KMDA)

Kamada Ltd. maintains its leadership in the production of plasma-derived therapies for the treatment of rare lung pathologies. The current revenue multiple on GURU.Markets contains data where 2.40 is the current value of the indicator. Business stability relies on government contracts and pipeline diversification, although dependence on raw materials and regulatory pressure create risks for profitability.

KMDA: Multiplikator P/S Kamada Ltd. 04.07.2022 - 13.11.2026

Rincian metrik lan analitis perusahaan Kamada Corp (KMDA)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega kamada.com|KMDA - Bagan rega target
- data kapitalisasi bursa:
Biji pasar Kamada Corp|KMDA - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi Saham Kamada|KMDA - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku kamada.com|KMDA - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Kamada Ltd.|KMDA - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Kamada Pharma|KMDA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Kamada Corp|KMDA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Kamada|Rasio cepet kamada.com
- informasi bathi lan kelipatan valuasi:
KMDA - Bathi resik perusahaan|Bathi mangsa ngarep Kamada Ltd.|KMDA - Pangali P/E|Pangali Forward P/E Kamada Ltd|KMDA - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan Kamada Corp|KMDA - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Kamada|KMDA - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan kamada.com|KMDA - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kamada Ltd.
- rincian pendapatan lan dodolan emiten:
KMDA - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan kamada.com|KMDA - Multiplikator P/S|Kapitalisasi marang prakiraan pendapatan Kamada Corp
Analisis umum perusahaan:KMDA kamada.com
Produk dadi Kamada Ltd.

Investors are assessing the potential of Kamada Ltd. (KMDA) through the price-to-sales ratio, which determines the value of each dollar of revenue. By analyzing this P/S chart, one can identify asset overheating, given the stable demand for life-saving plasma-derived therapies that renders the business resilient to economic cycles and market volatility.

Pesaing Kamada Ltd.

VRTX (vrtx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alnylam ALNY|INSM (Insmed Inc.) - Rasio rega marang dodolan|United Therapeutics Corp. - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan BMRN (BioMarin Corp)|BBIO: Multiplikator P/S|BGM Group (BGM) - Multiplikator P/S|Rasio rega marang pendapatan Cogent Biosciences, Inc.|XERS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Keros Pharma (KROS)|Kapitalisasi marang pendapatan Arcturus Corp ARCT|Multiplikator P/S ETON (Eton Pharmaceuticals)|Multiplikator P/S fulcrumtx.com FULC|ABEO - Rasio rega marang pendapatan|MREO - Multiplikator P/S|PLX: Multiplikator P/S|Pliant Therapeutics, Inc. (PLRX) - Multiplikator P/S|Rasio rega marang pendapatan Applied Therapeutics|Kapitalisasi marang pendapatan aileronrx.com (RNTX)|Multiplikator P/S GELS|Multiplikator P/S aytubio.com (AYTU)|Multiplikator P/S CMMB (Chemomab Therapeutics Ltd.)|SRXH: Rasio kapitalisasi marang pendapatan|Polyrizon Ltd. - Multiplikator P/S|AEZS - Multiplikator P/S|CYTH (Cyclo Therapeutics, Inc.) - Kapitalisasi marang pendapatan|Inozyme Pharma - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Reneo Pharma|Rasio rega marang pendapatan CSCI